MDI multiple daily injection
Selected indexed studies
- Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. (Diabetes Technol Ther, 2017) [PMID:28585879]
- The Utility of Smart Multiple Daily Injection Systems in Intensive Insulin-Treated People With Diabetes: An Italian Expert Consensus. (J Diabetes Sci Technol, 2025) [PMID:39927665]
- Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. (Lancet, 2008) [PMID:18502299]
_Worker-drafted node — pending editorial review._
Connections
MDI multiple daily injection is a side effect of
Sources
- Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. (2017) pubmed
- The Utility of Smart Multiple Daily Injection Systems in Intensive Insulin-Treated People With Diabetes: An Italian Expert Consensus. (2025) pubmed
- Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. (2008) pubmed
- Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes. (2024) pubmed
- Predictive value of postprandial C-peptide for utilizing multiple daily injection therapy in type 2 diabetes. (2024) pubmed
- Postnatal growth of Infants with neonatal diabetes: insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy. (2019) pubmed
- Nighttime hypoglycemia in Japanese children with type 1 diabetes mellitus treated with multiple daily injection insulin therapy. (2023) pubmed
- Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study. (2019) pubmed
- Assessing depressive symptoms and diabetes distress in Type 1 diabetic adults: A comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) users. (2023) pubmed
- Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study. (2016) pubmed